Chronic Myeloid Leukemia as Secondary Malignancy Following the Treatment of Hodgkin Lymphoma: A Case Series.
Document Type
Journal Article
Publication Date
8-1-2019
Journal
Anticancer Research
Volume
39
Issue
8
Inclusive Pages
4333-4335
DOI
10.21873/anticanres.13600
Keywords
Fusion Proteins, bcr-abl; Hodgkin Disease; Humans; Janus Kinase 2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Mutation; Neoplasms, Second Primary; Proto-Oncogene Proteins c-bcr
APA Citation
Millett, R., Aggarwal, A., Tabbara, I., & Nassereddine, S. (2019). Chronic Myeloid Leukemia as Secondary Malignancy Following the Treatment of Hodgkin Lymphoma: A Case Series.. Anticancer Research, 39 (8). http://dx.doi.org/10.21873/anticanres.13600
Peer Reviewed
1
